Company Overview Fulcrum Therapeutics is a clinical stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum's lead program in clinical development is pociredir, a small molecule…
About Fulcrum Therapeutics Fulcrum Therapeutics, Inc. ("Fulcrum") [NASDAQ: FULC] is a clinical stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum's lead…